Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Other Non Operating Income (2021 - 2025)

Senti Biosciences has reported Other Non Operating Income over the past 5 years, most recently at $200000.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at $200000.0 for Q4 2025, down 2.91% from a year ago — trailing twelve months through Dec 2025 was $801000.0 (up 298.51% YoY), and the annual figure for FY2025 was $800000.0, up 300.0%.
  • Other Non Operating Income for Q4 2025 was $200000.0 at Senti Biosciences, down from $223000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for SNTI hit a ceiling of $1.3 million in Q2 2022 and a floor of -$120000.0 in Q4 2021.
  • Median Other Non Operating Income over the past 5 years was $1000.0 (2023), compared with a mean of $210000.0.
  • Biggest five-year swings in Other Non Operating Income: tumbled 100.53% in 2023 and later surged 3233.33% in 2025.
  • Senti Biosciences' Other Non Operating Income stood at -$120000.0 in 2021, then soared by 1197.5% to $1.3 million in 2022, then tumbled by 100.53% to -$7000.0 in 2023, then skyrocketed by 3042.86% to $206000.0 in 2024, then dropped by 2.91% to $200000.0 in 2025.
  • The last three reported values for Other Non Operating Income were $200000.0 (Q4 2025), $223000.0 (Q3 2025), and $200000.0 (Q2 2025) per Business Quant data.